Economic burden associated with inadequate antidepressant medication management among patients with depression and known cardiovascular diseases: insights from a United States–based retrospective claims database analysis

References

• Heidenreich PA, Trogdon JG, Khavjou OA. Forecasting the future of cardiovascular disease in the United States. Circulation. 2011;123(8):933.
   PubMed Web of Science ®Google Scholar
• Fan AZ, Strine TW, Jiles R, et al. Depression and anxiety associated with cardiovascular disease among persons aged 45 years and older in 38 states of the United States, 2006. Prev Med. 2008;46(5):445–450.
   PubMed Web of Science ®Google Scholar
• Ha J-H, Wong C-K. Pharmacologic treatment of depression in patients with myocardial infarction. J Geriatr Cardiol. 2011;8(2):121–126.
   PubMedGoogle Scholar
• Bradley SM, Rumsfeld JS. Depression and cardiovascular disease. Trends Cardiovasc Med. 2015;25(7):614–622.
   PubMed Web of Science ®Google Scholar
• Rutledge T, Vaccarino V, Johnson BD, et al. Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2009;53(2):176–183.
   PubMed Web of Science ®Google Scholar
• Towfighi A, Ovbiagele B, El Husseini N, et al. Poststroke depression: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48(2):e30–e43.
   PubMed Web of Science ®Google Scholar
• Chang L, Liu N. The safety, efficacy, and tolerability of pharmacological treatment of depression in patients with cardiovascular disease: a look at antidepressants and integrative approaches. Heart and Mind. 2017;1(1):8–16.
   Google Scholar
• Myers V, Gerber Y, Benyamini Y, et al. Post-myocardial infarction depression: increased hospital admissions and reduced adoption of secondary prevention measures – a longitudinal study. J Psychosom Res. 2012;72(1):5–10.
   PubMed Web of Science ®Google Scholar
• Chung ML, Dekker RL, Lennie TA, et al. Antidepressants do not improve event-free survival in patients with heart failure when depressive symptoms remain. Heart Lung. 2013;42(2):85–91.
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lespérance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91(4):999–1005.
   PubMed Web of Science ®Google Scholar
• Lichtman JH, Bigger JT, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768–1775.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Shah R, Pappadopulos E, et al. Cardiovascular hazards of insufficient treatment of depression among patients with known cardiovascular disease: a propensity score adjusted analysis. Euro Heart J Qual Care Clin Outc. 2018;4(4):258–266.
   PubMed Web of Science ®Google Scholar
• Husaini B, Levine R, Sharp L, et al. Depression increases stroke hospitalization cost: an analysis of 17,010 stroke patients in 2008 by race and gender. Stroke Res Treat. 2013;2013:846732.
   PubMedGoogle Scholar
• IBM Watson Health. IBM MarketScan Research Databases for Health Services Researchers (White Paper). 2018 [cited 2019 Nov 4]. Available from: https://www.ibm.com/downloads/cas/6KNYVVQ2
   Google Scholar
• Gelenberg A, Freeman M, Markowitz J, et al. Practice guideline for the treatment of patients with Major Depressive Disorder: third edition. San Fransisco (CA): American Psychiatric Association; 2010.
   Google Scholar
• Charbonneau A, Rosen AK, Owen RR, et al. Monitoring depression care: in search of an accurate quality indicator. Med Care. 2004;42(6):522–531.
   PubMed Web of Science ®Google Scholar
• Westreich D, Cole SR, Funk MJ, et al. The role of the c-statistic in variable selection for propensity score models. Pharmacoepidem Drug Safe. 2011;20(3):317–320.
   PubMed Web of Science ®Google Scholar
• Sullivan M, Simon G, Spertus J, et al. Depression-related costs in heart failure care. Arch Intern Med. 2002;162(16):1860–1866.
   PubMedGoogle Scholar
• Jia H, Damush TM, Qin H, et al. The impact of poststroke depression on healthcare use by veterans with acute stroke. Stroke. 2006;37(11):2796–2801.
   PubMed Web of Science ®Google Scholar
• Ghose SS, Williams LS, Swindle RW. Depression and other mental health diagnoses after stroke increase inpatient and outpatient medical utilization three years poststroke. Med Care. 2005;43(12):1259–1264.
   PubMed Web of Science ®Google Scholar
• McFarlane A, Kamath MV, Fallen EL, et al. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am Heart. 2001;142(4):617–623.
   PubMed Web of Science ®Google Scholar
• Yekehtaz H, Farokhnia M, Akhondzadeh S. Cardiovascular considerations in antidepressant therapy: an evidence-based review. J Tehran Heart Cent. 2013;8(4):169.
   PubMedGoogle Scholar
• Feinstein RE, Blumenfield M, Orlowski B, et al. A national survey of cardiovascular physicians’ beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease. Cardio Rev. 2006;14(4):164–169.
   PubMedGoogle Scholar
• Panzarino PJ, Jr. The costs of depression: direct and indirect; treatment versus nontreatment J Clin Psychiatry. 1998;59(20):11–14.
   Google Scholar
• Davidson JR, Meltzer-Brody SE. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? J Clin Psychiatry. 1999;60(7):4–9.
   PubMed Web of Science ®Google Scholar
• Crystal S, Akincigil A, Bilder S, et al. Studying prescription drug use and outcomes with Medicaid claims data strengths, limitations, and strategies. Med Care. 2007;45(2):S58–S65.
   PubMedGoogle Scholar
• Kennedy SH, Lam RW, McIntyre RS, et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry. 2016;61(9):540–560.
   PubMed Web of Science ®Google Scholar